|
[1]
|
Schneider, B.J., et al. (2020) Lung Cancer Surveillance after Definitive Curative-Intent Therapy: ASCO Guideline. Journal of Clinical Oncology, 38, 753-766. [Google Scholar] [CrossRef]
|
|
[2]
|
Bade, B.C. and Dela Cruz, C.S. (2020) Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clinics in Chest Medicine, 41, 1-24. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Balata, H., et al. (2019) Prevention and Early Detection for NSCLC: Advances in Thoracic Oncology 2018. Journal of Thoracic Oncology, 14, 1513-1527. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Zhou, Y., et al. (2011) GPU Accelerated Biochemical Network Simulation. Bioinformatics, 27, 874-876. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Nobile, M.S., et al. (2017) Graphics Processing Units in Bioinformatics, Computational Biology and Systems Biology. Briefings in Bioinformatics, 18, 870-885.
|
|
[6]
|
Chaudhary, K., et al. (2018) Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer. Clinical Cancer Research, 24, 1248-1259. [Google Scholar] [CrossRef]
|
|
[7]
|
Qiu, Z., et al. (2019) A Pharmacogenomic Landscape in Human Liver Cancers. Cancer Cell, 36, 179-193.e11. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Giacoia, E.G., et al. (2014) PAI-1 Leads to G1-Phase Cell-Cycle Progression through Cyclin D3/cdk4/6 Upregulation. Molecular Cancer Research, 12, 322-334. [Google Scholar] [CrossRef]
|
|
[9]
|
Zhang, W., et al. (2018) Endothelial Cells Promote Triple-Negative Breast Cancer Cell Metastasis via PAI-1 and CCL5 Signaling. The FASEB Journal, 32, 276-288. [Google Scholar] [CrossRef]
|
|
[10]
|
Xu, J., et al. (2018) Epithelial-Mesenchymal Transition Induced PAI-1 Is Associated with Prognosis of Triple-Negative Breast Cancer Patients. Gene, 670, 7-14. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Luo, C., et al. (2017) Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1) Upregulated by Helicobacter pylori and Is Associated with Gastric Cancer Cells Migration. Pathology—Research and Practice, 213, 1029-1036. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Geis, T., et al. (2015) HIF-2α Attenuates Lymphangiogenesis by Up-Regulating IGFBP1 in Hepatocellular Carcinoma. Biology of the Cell, 107, 175-188. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Feng, H., et al. (2019) Identification of Significant Genes with Poor Prognosis in Ovarian Cancer via Bioinformatical Analysis. Journal of Ovarian Research, 12, 35. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
(2020) Erratum: Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 70, 313. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2020) Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Simone, T.M., et al. (2015) Targeted Inhibition of PAI-1 Activity Impairs Epithelial Migration and Wound Closure Following Cutaneous Injury. Advances in Wound Care (New Rochelle), 4, 321-328. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Liao, P., et al. (2018) Genome-Scale Analysis Identifies SERPINE1 and SPARC as Diagnostic and Prognostic Biomarkers in Gastric Cancer. OncoTargets and Therapy, 11, 6969-6980. [Google Scholar] [CrossRef]
|
|
[18]
|
Zhang, Q., Lei, L. and Jing, D. (2020) Knockdown of SERPINE1 Reverses Resistance of Triple-Negative Breast Cancer to Paclitaxel via Suppression of VEGFA. Oncology Reports, 44, 1875-1884. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Sakamoto, H., et al. (2020) PAI-1 Derived from Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma Promotes the Invasion of Cancer Cells and the Migration of Macrophages. Laboratory Investigation, 101, 353-368. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Arroyo-Solera, I., et al. (2019) Effect of serpinE1 Overexpression on the Primary Tumor and Lymph Node, and Lung Metastases in Head and Neck Squamous Cell Carcinoma. Head Neck, 41, 429-439. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Katanasaka, Y., et al. (2014) Synergistic Anti-Tumor Effects of a Novel Phosphatidyl Inositol-3 Kinase/Mammalian Target of Rapamycin Dual Inhibitor BGT226 and Gefitinib in Non-Small Cell Lung Cancer Cell Lines. Cancer Letters, 347, 196-203. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Gęca, T. and Kwaśniewska, A. (2020) The Influence of Gestational Diabetes Mellitus upon the Selected Parameters of the Maternal and Fetal System of Insulin-Like Growth Factors (IGF-1, IGF-2, IGFBP1-3)—A Review and a Clinical Study. Journal of Clinical Medicine, 9, 3256. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Kashyap, M.K. (2015) Role of Insulin-Like Growth Factor-Binding Proteins in the Pathophysiology and Tumorigenesis of Gastroesophageal Cancers. Tumor Biology, 36, 8247-8257. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Fürstenberger, G. and Senn, H.J. (2002) Insulin-Like Growth Factors and Cancer. The Lancet Oncology, 3, 298-302. [Google Scholar] [CrossRef]
|
|
[25]
|
Leu, J.I., Crissey, M.A. and Taub, R. (2003) Massive Hepatic Apoptosis Associated with TGF-beta1 Activation after Fas Ligand Treatment of IGF Binding Protein-1-Deficient Mice. The Journal of Clinical Investigation, 111, 129-139. [Google Scholar] [CrossRef]
|
|
[26]
|
Zheng, F., et al. (2018) Inactivation of Stat3 and Crosstalk of miRNA155-5p and FOXO3a Contribute to the Induction of IGFBP1 Expression by Beta-Elemene in Human Lung Cancer. Experimental & Molecular Medicine, 50, 121. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Sharma, J., et al. (2014) Elevated Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1) in Men with Metastatic Prostate Cancer Starting Androgen Deprivation Therapy (ADT) Is Associated with Shorter Time to Castration Resistance and Overall Survival. Prostate, 74, 225-234. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Zheng, Y., Sowers, J.Y. and Houston, K.D. (2020) IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation. Frontiers in Endocrinology (Lausanne), 11, 233. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Yang, L.J., et al. (2016) Inter-Regulation of IGFBP1 and FOXO3a Unveils Novel Mechanism in Ursolic Acid-Inhibited Growth of Hepatocellular Carcinoma Cells. Journal of Experimental & Clinical Cancer Research, 35, 59. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Tang, Q., et al. (2017) Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer. Cellular Physiology and Biochemistry, 41, 339-357. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Cao, Y., et al. (2015) Prediagnostic Plasma IGFBP-1, IGF-1 and Risk of Prostate Cancer. International Journal of Cancer, 136, 2418-2426. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Shafiee, M.N., et al. (2016) Up-Regulation of Genes Involved in the Insulin Signalling Pathway (IGF1, PTEN and IGFBP1) in the Endometrium May Link Polycystic Ovarian Syndrome and Endometrial Cancer. Molecular and Cellular Endocrinology, 424, 94-101. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Gong, J., et al. (2017) Inhibition of FASN Suppresses Migration, Invasion and Growth in Hepatoma Carcinoma Cells by Deregulating the HIF-1α/IGFBP1 Pathway. International Journal of Oncology, 50, 883-892. [Google Scholar] [CrossRef] [PubMed]
|